Methods for treating cancer

The present invention relates to methods for treating cancer in a subject using a cancer immunotherapy such as a PD-L1 binding protein, such as an anti-PD-L1 antibody (e.g. atezolizumab) in combination with implementing a digital patient monitoring method that comprises receiving reports of one or m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BUSTILLOS RODRIGUEZ, ALBERTO EDGARDO, AMMANN, JOHANNES ULRICH, MUELLER-OHLDACH, MATHIS DANIEL, CASTRO SANCHEZ, AMPARO YOVANNA
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA HUMAN NECESSITIES HYGIENE INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to methods for treating cancer in a subject using a cancer immunotherapy such as a PD-L1 binding protein, such as an anti-PD-L1 antibody (e.g. atezolizumab) in combination with implementing a digital patient monitoring method that comprises receiving reports of one or more predetermined symptoms, whether the reported symptoms are in at least a first category or a second category, and in response to receiving a report of a predetermined symptom in said subject in the first category, performing a first action comprising providing self-management information specific to the predetermined symptom to the subject, wherein the predetermined symptoms are cancer and cancer immunotherapy-specific.